CHA Biotech Co. Ltd (085660) — Long-term Investment Intensity

Latest as of September 2019: 10.6%

CHA Biotech Co. Ltd (085660) has a Long-term Investment Intensity of 10.6% as of September 2019. Long-term investments of ₩122.58 Billion represent 10.6% of total assets of ₩1.16 Trillion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check financial resilience of CHA Biotech Co. Ltd to evaluate the company's liquid asset resilience ratio.

LT Investment Intensity

10.6%
LT Investments / Total Assets

Long-term Investments

₩122.58 Billion
KRW

Total Assets

₩1.16 Trillion
KRW

Country

Korea
KQ

CHA Biotech Co. Ltd Long-term Investment Intensity (2014–2018)

This chart shows how CHA Biotech Co. Ltd's Long-term Investment Intensity has evolved across 5 annual periods from 2014 to 2018. As of September 2019, the intensity stands at 10.6%, reflecting long-term investments of ₩122.58 Billion against total assets of ₩1.16 Trillion KRW. For the complete balance sheet picture, see CHA Biotech Co. Ltd asset portfolio.

Annual Long-term Investment Intensity for CHA Biotech Co. Ltd (2014–2018)

The table below presents the year-by-year Long-term Investment Intensity for CHA Biotech Co. Ltd from 2014 to 2018, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read 085660 total liabilities for a breakdown of total debt and financial obligations.

Year LT Investment Intensity LT Investments (KRW) Total Assets Change (pp)
2018 6.3% ₩59.53 Billion ₩947.53 Billion ▲ +0.9 pp
2017 5.3% ₩42.35 Billion ₩793.61 Billion ▲ +3.0 pp
2016 2.4% ₩18.08 Billion ₩768.93 Billion ▲ +0.8 pp
2015 1.5% ₩9.89 Billion ₩644.83 Billion ▼ -1.1 pp
2014 2.6% ₩16.23 Billion ₩620.88 Billion
pp = percentage points